Poseida Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
1/17/2025
Shares
329
Value ($000)
3
Weight
0.0%
2021 Q2 - 2024 Q4 (8 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).